mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.7 |
mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.027 |
0.7 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |